| Nephron‐sparing surgery across a nation–outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit A Fernando, S Fowler, T O'Brien, ... BJU international 117 (6), 874-882, 2016 | 48 | 2016 |
| Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo KJ Bowman, MM Al‐Moneef, BT Sherwood, AJ Colquhoun, JC Goddard, ... International journal of cancer 134 (5), 1102-1111, 2014 | 40 | 2014 |
| The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer–a multicentre observational study S Khadhouri, KM Gallagher, KR MacKenzie, TT Shah, C Gao, S Moore, ... BJU international 128 (4), 440-450, 2021 | 39 | 2021 |
| Measures of cisplatin and mitomycin C-induced DNA crosslink formation, as determined by comet assay, predicts in vitro bladder cancer cell chemosensitivity M Al-Moneef, BT Sherwood, KJ Bowman, RC Kockelbergh, RP Symonds, ... Mutagenesis 19 (6), 515-515, 2004 | 1 | 2004 |
| Evaluation of the alkaline comet assay as a predictive test of bladder cancer cell radiosensitivity BT Sherwood, M Al Moneef, KJ Bowman, RC Kockelbergh, RP Symonds, ... BJU INTERNATIONAL 92 (7), 826-826, 2003 | 1 | 2003 |
| Measures of DNA damage and bladder cancer cell treatment response KJ Bowman, M Al Moneef, BT Sherwood, RC Kockelbergh, RP Symonds, ... MUTAGENESIS 27 (1), 104-104, 2012 | | 2012 |
| Measures of DNA damage sensitivity are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo. M Al-Moneef, B Sherwood, A Colquhoun, J Goddard, L Griffiths, D Payne, ... | | |
